Harvard Bioscience, Inc. (HBIO) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 20.75M | 23.73M | 20.59M | 20.45M | 21.77M | 24.56M | 21.97M | 23.1M | 24.51M | 28.15M | 25.36M | 28.76M |
| Revenue Growth % | -4.68% | -3.34% | -6.28% | -11.46% | -11.17% | -12.78% | -13.38% | -19.69% | -18.23% | -0.96% | -5.79% | -1.54% |
| Cost of Goods Sold | 8.51M | 9.56M | 8.57M | 10.08M | 9.59M | 10.54M | 9.21M | 9.88M | 9.74M | 13.21M | 10.64M | 12.09M |
| COGS % of Revenue | 41.01% | 40.29% | 41.62% | 49.29% | 44.04% | 42.94% | 41.9% | 42.77% | 39.74% | 46.94% | 41.94% | 42.03% |
| Gross Profit | 12.24M | 14.17M | 12.02M | 10.37M | 12.18M | 14.01M | 12.77M | 13.22M | 14.77M | 14.94M | 14.73M | 16.67M |
| Gross Margin % | 58.99% | 59.71% | 58.38% | 50.71% | 55.96% | 57.06% | 58.1% | 57.23% | 60.26% | 53.06% | 58.06% | 57.97% |
| Gross Profit Growth % | 0.49% | 1.15% | -5.83% | -21.54% | -17.52% | -6.21% | -13.32% | -20.72% | -19.48% | -5.65% | 20.99% | 0.22% |
| Operating Expenses | 12.36M | 12.24M | 11.82M | 11.19M | 61.85M | 14M | 14.64M | 15.29M | 17.05M | 14.66M | 15.66M | 15.88M |
| OpEx % of Revenue | 59.57% | 51.59% | 57.42% | 54.72% | 284.06% | 57.01% | 66.63% | 66.19% | 69.56% | 52.06% | 61.74% | 55.21% |
| Selling, General & Admin | 10.04M | 9.21M | 8.79M | 8.8M | 10.16M | 10.2M | 10.56M | 11.08M | 11.87M | 11.51M | 11.54M | 11.53M |
| SG&A % of Revenue | 48.36% | 38.81% | 42.68% | 43.04% | 46.64% | 41.53% | 48.06% | 47.98% | 48.41% | 40.87% | 45.5% | 40.1% |
| Research & Development | 2.33M | 2.18M | 2.13M | 2.19M | 2.32M | 2.33M | 2.57M | 2.63M | 2.88M | 3.15M | 2.76M | 2.96M |
| R&D % of Revenue | 11.21% | 9.2% | 10.35% | 10.7% | 10.66% | 9.48% | 11.68% | 11.37% | 11.77% | 11.19% | 10.88% | 10.28% |
| Other Operating Expenses | 0 | 850K | 903K | 200K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 1000K | 1000K |
| Operating Income | -119K | 1.93M | 197K | -819K | -49.67M | 11K | -1.87M | -2.07M | -2.28M | 282K | -933K | 796K |
| Operating Margin % | -0.57% | 8.12% | 0.96% | -4% | -228.11% | 0.04% | -8.53% | -8.96% | -9.3% | 1% | -3.68% | 2.77% |
| Operating Income Growth % | 99.76% | 17418.18% | 110.51% | 60.42% | -2079.38% | -96.1% | -100.86% | -359.92% | -230.3% | 161.71% | 75.2% | -80.09% |
| EBITDA | -119K | 3.28M | 1.52M | 799K | -48.01M | 1.77M | -59K | -268K | -498K | 2.06M | 846K | 2.52M |
| EBITDA Margin % | -0.57% | 13.81% | 7.39% | 3.91% | -220.51% | 7.21% | -0.27% | -1.16% | -2.03% | 7.3% | 3.34% | 8.75% |
| EBITDA Growth % | 99.75% | 85.04% | 2677.97% | 398.13% | -9541.16% | -13.82% | -106.97% | -110.65% | -114.35% | 36.64% | 146.33% | -56.81% |
| D&A (Non-Cash Add-back) | 0 | 1.35M | 1.32M | 1.62M | 1.66M | 1.76M | 1.81M | 1.8M | 1.78M | 1.77M | 1.78M | 1.72M |
| EBIT | -119K | -846K | -168K | -1.46M | -49.99M | 1.44M | -3.63M | -2.53M | -3.73M | -309K | 320K | -1.16M |
| Net Interest Income | 1.73M | -2.36M | -966K | -791K | -802K | -853K | -856K | -749K | -751K | -794K | -882K | -941K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -1.73M | 2.36M | 966K | 791K | 802K | 853K | 856K | 749K | 751K | 794K | 882K | 941K |
| Other Income/Expense | -3.19M | -5.13M | -1.33M | -1.44M | -1.13M | 579K | -2.62M | -1.21M | -2.21M | -1.39M | 371K | -2.89M |
| Pretax Income | -3.31M | -3.2M | -1.13M | -2.25M | -50.79M | 590K | -4.49M | -3.28M | -4.48M | -1.1M | -562K | -2.1M |
| Pretax Margin % | -15.93% | -13.5% | -5.51% | -11.02% | -233.28% | 2.4% | -20.44% | -14.2% | -18.29% | -3.92% | -2.22% | -7.3% |
| Income Tax | 117K | -357K | 97K | 28K | -454K | 572K | 311K | -353K | 210K | 715K | 677K | -1.12M |
| Effective Tax Rate % | -3.54% | 11.14% | -8.55% | -1.24% | 0.89% | 96.95% | -6.92% | 10.76% | -4.68% | -64.82% | -120.46% | 53.29% |
| Net Income | -3.42M | -2.85M | -1.23M | -2.28M | -50.34M | 18K | -4.8M | -2.93M | -4.69M | -1.82M | -1.24M | -980K |
| Net Margin % | -16.5% | -11.99% | -5.98% | -11.16% | -231.19% | 0.07% | -21.86% | -12.67% | -19.15% | -6.46% | -4.89% | -3.41% |
| Net Income Growth % | 93.2% | -15916.67% | 74.36% | 22.04% | -972.43% | 100.99% | -287.57% | -198.67% | -854.66% | -9.12% | 63.61% | -140.25% |
| Net Income (Continuing) | -3.42M | -2.85M | -1.23M | -2.28M | -50.34M | 18K | -4.8M | -2.93M | -4.69M | -1.82M | -1.24M | -980K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.77 | -0.64 | -0.28 | -0.52 | -11.40 | 0.00 | -1.10 | -0.67 | -1.10 | -0.43 | -0.29 | -0.23 |
| EPS Growth % | 93.25% | - | 74.91% | 23.48% | -936.36% | 100.94% | -279.31% | -191.34% | -858.62% | -7.58% | 64.55% | -140.38% |
| EPS (Basic) | -0.77 | -0.64 | -0.28 | -0.52 | -11.40 | 0.00 | -1.10 | -0.67 | -1.10 | -0.43 | -0.29 | -0.23 |
| Diluted Shares Outstanding | 4.47M | 4.44M | 4.46M | 4.43M | 4.41M | 4.35M | 4.36M | 4.35M | 4.34M | 4.27M | 4.27M | 4.24M |
| Basic Shares Outstanding | 4.47M | 4.44M | 4.46M | 4.43M | 4.41M | 4.35M | 4.36M | 4.35M | 4.34M | 4.27M | 4.27M | 4.24M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |